Lecithin
SupplementThe medical score (52) is lower than the community score (62) because some users in r/Nootropics subjectively report strong cognitive effects [c1] that have not been consistently reproduced in RCTs [s2]. Conversely, informed community members rate the TMAO risk [s13] higher than average consumers.
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
Lecithin is a cheap and safe choline source, but cognitive expectations should be tempered: the Cochrane review found no convincing benefit in dementia, and robust human data for healthy individuals simply don't exist. Small studies show weak positive signals for LDL reduction and liver protection — interesting but not conclusive. The most relevant safety concern is TMAO: gut bacteria convert phosphatidylcholine into TMAO, a metabolite with cardiovascular risk implications, and this is a legitimate concern actively debated in the community. Switching to sunflower lecithin addresses allergy and GMO concerns, but whether it meaningfully reduces TMAO production in humans remains unproven.
Description
Lipid mixture of phospholipids (primarily phosphatidylcholine) serving as a choline source, emulsifier, and potential hepatoprotective agent; evidence for cognitive effects in humans is limited [s1, s2].
Lecithin is a natural mixture of phospholipids consisting of approximately 25–35% phosphatidylcholine (PC) [s1]. It is derived from soybeans, sunflowers, egg yolk, and other plant or animal sources. As a dietary supplement, it serves primarily as a choline source: the body enzymatically cleaves PC to free choline, which is then required for synthesis of the neurotransmitter acetylcholine and for structural cell membrane functions [s2, s3]. In the food industry, lecithin (E 322) is widely used as an emulsifier [s11]. As a supplement, it is discussed for the following applications: improvement of cognition via elevation of choline levels [s2], hepatoprotection in fatty liver disease [s5, s6], reduction of LDL cholesterol [s7], and — without robust clinical trials — prevention of milk duct blockages during breastfeeding [s9]. Regarding safety, one potentially adverse effect warrants attention: gut bacteria can convert choline from lecithin to trimethylamine (TMA), which is oxidized in the liver to trimethylamine N-oxide (TMAO) — a metabolite associated with increased cardiovascular risk in epidemiological studies [s13]. Whether this effect is clinically relevant at moderate lecithin supplementation remains controversial [s14]. Sunflower lecithin is considered a lower-allergen alternative to soy lecithin; both forms hold GRAS status in the USA and have been evaluated by EFSA without safety concerns at customary use levels [s10, s11].
Legal Status (DE)
Lecithin (E 322) is approved in the EU as a food additive [s11] and is marketable in Germany as an over-the-counter dietary supplement (NEM) without quantity restrictions under the EU dietary supplement directive [s12]. No prescription-only status; freely available in retail.
Mechanism of Action
1. Cholinergic signaling: Phosphatidylcholine from lecithin is hydrolyzed to choline by intestinal phospholipases. Choline is synthesized into acetylcholine via choline acetyltransferase, the principal neurotransmitter for memory and muscle contraction. Increased acetylcholine synthesis is considered the primary mechanism for potential cognitive effects [s2, s3]. 2. Cell membrane integrity: Phosphatidylcholine is a major constituent of biological membranes. Adequate PC intake supports membrane fluidity and repair mechanisms, particularly in hepatocytes [s5, s6]. 3. Reverse cholesterol transport: Lecithin-cholesterol acyltransferase (LCAT) catalyzes the esterification of free cholesterol into HDL particles, thereby promoting reverse cholesterol transport. Lecithin provides the substrate for LCAT and may thereby lower LDL and raise HDL [s8]. 4. TMAO pathway (potentially adverse): Gut bacteria convert choline from PC to TMA; hepatic FMO3 oxidizes TMA to TMAO. Elevated TMAO levels are associated with proatherogenic effects, although the causal relationship in humans remains under debate [s13, s14]. 5. Fatty acid bioavailability: Phospholipid-bound omega-3 fatty acids (e.g., from rapeseed oil lecithin) demonstrate increased bioavailability compared to triglyceride form in animal studies and small human trials [s4].
Dosing
Cholinversorgung (allgemein)
- Dose
- 1200–2400 mg lecithin (approx. 300–600 mg phosphatidylcholine)
- Frequency
- 1–3× täglich
- Route
- oral
- Duration
- fortlaufend
- Timing
- With meals
- With food
- empfohlen
LDL-Cholesterin-Senkung
- Dose
- 500 mg soy lecithin granules daily
- Frequency
- 1× täglich
- Route
- oral
- Duration
- 2 Monate
- Timing
- In the morning with breakfast
- With food
- empfohlen
Leberschutz / Fettleber (essenzielle Phospholipide)
- Dose
- 1500–1800 mg phosphatidylcholine
- Frequency
- aufgeteilt auf 3 Dosen
- Route
- oral
- Duration
- 4–12 Wochen
- Timing
- With meals
- With food
- empfohlen
Milchgangsverstopfung beim Stillen (empirisch)
- Dose
- 3600–4800 mg lecithin
- Frequency
- aufgeteilt auf 3–4 Dosen
- Route
- oral
- Duration
- nach Bedarf
- Timing
- With meals
- With food
- empfohlen
No official Tolerable Upper Intake Level (UL) established by EFSA or BfR for lecithin as a dietary supplement [s11, s12]. The NIH choline UL is 3500 mg choline/day for adults; lecithin contains approximately 15% choline [s15].
Lecithin contains varying PC fractions (25–35%) depending on source and processing. Granules and capsules vary considerably in phosphatidylcholine concentration. For TMAO concerns: consider fish oil as an alternative phospholipid source, as fish-derived PC induces less TMAO [s14].
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Gastrointestinale Beschwerden (Durchfall, weicher Stuhl, Übelkeit, Blähungen) Most common adverse effect at higher doses; can be reduced by taking with meals and slow dose escalation [s16, c4]. | gelegentlich | leicht |
| Erhöhte TMAO-Spiegel im Blut Gut bacteria-mediated conversion of phosphatidylcholine to TMA and TMAO; demonstrated in human studies; long-term clinical relevance unclear but potentially proatherogenic [s13, s14]. | häufig | moderat |
| Allergische Reaktionen (Hautausschlag, Urtikaria, Atemnot) Possible primarily with soy lecithin in cases of soy allergy, even though allergenic proteins are largely removed during processing [s16]. | selten | schwer |
| Fischartiger Körpergeruch (Trimethylaminurie) Possible with excessively high choline/lecithin intake or in individuals with reduced FMO3 enzyme activity (trimethylaminuria) [s15]. | selten | leicht |
| Milde Tagesmüdigkeit oder Kopfschmerzen Mentioned sporadically in user reports; no established mechanism known; possibly dose-dependent [c1]. | selten | leicht |
Contraindications
Although soy lecithin contains only trace amounts of soy protein, isolated allergic reactions in soy-allergic individuals have been reported. AAAAI recommends individual risk assessment [s16].
Reduced FMO3 activity leads to TMA accumulation upon choline/lecithin intake. Lecithin should be avoided in this condition [s15].
Potentially increased TMAO production from phosphatidylcholine may have proatherogenic effects; benefit-risk assessment required [s13].
No valid safety studies available for high-dose lecithin supplementation during pregnancy; normal dietary intake is safe [s9].
Interactions
Synergistic
Phospholipid-bound DHA from lecithin shows increased bioavailability compared to the triglyceride form in small studies; synergistic benefit for membrane composition possible [s4].
Combined intake additively increases plasma choline levels; relevant for choline-deficient individuals [s3, s15].
Lecithin provides phosphatidylcholine as a general choline source, while Alpha-GPC produces higher choline concentrations in the brain. A combination may broadly support plasma choline levels and complement cognitive effects.
Lecithin and citicoline both act as choline sources and phospholipid building blocks. Combined intake may synergistically support cell membranes and cognitive function.
Soy lecithin forms liposomal structures that encapsulate curcumin, markedly increasing its water solubility and gastrointestinal absorption. Studies demonstrate significantly higher bioavailability of lecithin-encapsulated curcumin compared to the free form.
CoQ10 is highly lipophilic; concurrent intake with lecithin-containing products or high-fat meals substantially increases absorption. Lecithin as an emulsifier can improve CoQ10 bioavailability.
Lecithin and krill oil share phospholipid-bound omega-3 fatty acids as a common building block for cell membranes. The combination may synergistically support membrane composition and further improve DHA/EPA bioavailability.
Caution
Lecithin may affect anticoagulant activity; close INR monitoring recommended [s16].
Moderate interaction described; consultation with a physician recommended [s16].
Lecithin may affect hepatic enzyme activity; interactions possible in polypharmacy settings [s16].
Studies
Tier A — High Evidence
Outcome: Reduction of total and LDL cholesterol
Effect Size: Significant reduction in total cholesterol and LDL during the first month of treatment
Outcome: Cognition and dementia progression with lecithin administration
Effect Size: No significant benefit over placebo in the majority of RCTs
Tier B — Moderate Evidence
Outcome: Liver echogenicity (ultrasound) in NAFLD
Effect Size: Reduction in liver echogenicity with phosphatidylcholine vs. placebo
Outcome: Role of LCAT and lecithin in reverse cholesterol transport
Effect Size: LDL-lowering and HDL-promoting mechanisms described
Outcome: TMAO levels and cardiovascular events
Effect Size: Elevated TMAO levels following phosphatidylcholine challenge; association with MACE
Tier C — Low Evidence
Outcome: Safety and efficacy of lecithin during breastfeeding
Effect Size: No valid clinical trials available
Outcome: Essential phospholipids in fatty liver disease
Effect Size: Acceleration of symptom improvement in fatty liver disease in older studies
Community Evidence
Top reported benefits
- Improved mental clarity and alertness (particularly soy lecithin)
- Support for milk duct blockages (sunflower lecithin)
- Better omega-3 absorption when taken in combination
- Perceived reduction in brain fog
Top reported issues
- TMAO concerns due to cardiovascular risk
- Gastrointestinal complaints (diarrhea, nausea)
- Skepticism toward soy lecithin due to GMO and allergy concerns
- No noticeable effect in a subset of users
The TMAO issue is intensively discussed in r/Nootropics and r/Biohackers and leads a considerable proportion of users to reject choline supplements including lecithin [c1, c2]. Some users explicitly prefer sunflower lecithin due to lower TMAO induction by phosphatidylcholine compared to other choline forms, although the evidence for this in humans is limited [c3].
Scientific Sources
- Lecithin - Wikipedia
Wikipedia contributors (2024). WikipediaDLink - Sunflower Lecithin vs Soy Lecithin: GRAS status and safety comparison
Thyme to Go Vegan RD (2023). Thyme to Go Vegan Nutrition ServicesCLink - Lebensmittelzusatzstoffe – Lecithin (E 322)
European Food Safety Authority (EFSA) (2023). EFSA / EU-KommissionALink - Directive 2002/46/EC on food supplements
European Parliament, Council of the European Union (2002). Official Journal of the European CommunitiesALink - Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
Tang WH, Wang Z, Levison BS, et al. (2013). New England Journal of MedicineAPMID:23614584DOI - Dietary Choline Supplements, but Not Eggs, Raise Fasting TMAO Levels in Participants with Normal Renal Function: A Randomized Clinical Trial
Fielding CJ, Hossain M, Bhagavan HN, et al. (2021). Journal of NutritionAPMID:34015106DOI - Choline – Dietary Reference Intakes (NCBI Bookshelf)
Institute of Medicine, National Academies (1998). National Academies PressALink - Lecithin: Uses, Side Effects, Interactions, Warnings & Dosing
WebMD / RxList editorial (2024). WebMD / RxListCLink - Composition of soybean lecithin
Szuhaj BF (1981). Journal of the American Oil Chemists' SocietyADOI - Verordnung über Nahrungsergänzungsmittel (Nahrungsergänzungsmittelverordnung – NemV)
Bundesministerium der Justiz (Deutschland) (2004). ALink - Phosphatidylcholine and Lecithin – Cognitive Vitality For Researchers
Alzheimer's Drug Discovery Foundation (2023). Alzheimer's Drug Discovery FoundationBLink - Choline – Health Professional Fact Sheet
National Institutes of Health, Office of Dietary Supplements (2023). NIH Office of Dietary SupplementsBLink - Lecithin: benefits, dosage, contraindications
Darwin Nutrition (2023). Darwin Nutrition (Review)CLink - Phosphatidylcholin: wichtig für die Leber und mehr
VitaminDoctor-Redaktion (2023). VitaminDoctorCLink - Essenzielle Phospholipide bei Fettlebererkrankungen
Sanofi / EFSM Editorial (2021). European Forum for Medical Science Online (efsm.online)CLink - Influence of Soy Lecithin Administration on Hypercholesterolemia
Mourad AM, de Carvalho Pincinato E, Mazzola PG, et al. (2010). CholesterolAPMID:21490949DOI - Lecithin and cardiovascular health: a comprehensive review
Dajani AI, Hebishy HM, Alnakshabandi A, et al. (2024). The Egyptian Heart JournalBPMID:39001966DOI - Lecithin – Drugs and Lactation Database (LactMed)
National Library of Medicine (2023). NCBI Bookshelf / LactMedBLink
Community Sources
Storage
Unopened
Store in a dry, cool (below 25 °C), light-protected environment; granules and capsules in original sealed packaging.
Opened
After opening, seal airtight; granules are prone to clumping and oxidation when exposed to heat and moisture.
Notes
Lecithin is susceptible to oxidation (unsaturated fatty acids); rancid odor is an indicator of quality degradation. Refrigerated storage extends the shelf life of opened granules.